Effects of combined treatment of tadalafil and tamsulosin on bladder dysfunction via the inhibition of afferent nerve activities in a rat model of bladder outlet obstruction

[1]  Y. Homma,et al.  Functional roles of bladder α1‐adrenoceptors in the activation of single‐unit primary bladder afferent activity in rats , 2016, BJU International.

[2]  S. Egawa,et al.  Combination therapy with β3‐adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity , 2016, International journal of urology : official journal of the Japanese Urological Association.

[3]  M. Takeda,et al.  Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action , 2015, Therapeutic advances in urology.

[4]  Y. Kawai,et al.  Effect of a single treatment with tadalafil on blood flow in lower urinary tract tissues in rat models of bladder overdistension/emptying and abdominal aorta clamping/release. , 2015, European journal of pharmacology.

[5]  F. Montorsi,et al.  Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates. , 2014, European journal of pharmacology.

[6]  A. Mandal,et al.  A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. , 2014, The journal of sexual medicine.

[7]  O. Yamaguchi,et al.  Effects of silodosin, a selective α1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction. , 2013, The Journal of urology.

[8]  Alexander Bachmann,et al.  EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. , 2013, European urology.

[9]  D. Burmeister,et al.  Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia. , 2013, The Journal of urology.

[10]  J. Wyndaele,et al.  Inhibitory effects of phosphodiesterase 5 inhibitor, tadalafil, on mechanosensitive bladder afferent nerve activities of the rat, and on acrolein‐induced hyperactivity of these nerves , 2012, BJU international.

[11]  P. Cuevas,et al.  Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. , 2012, The journal of sexual medicine.

[12]  Naoki Yoshimura,et al.  Physiology and Pharmacology of the Bladder and Urethra , 2012 .

[13]  H. Akino,et al.  Co‐administration of an α1‐blocker improves the efficacy and safety of antimuscarinic agents in rats with detrusor overactivity , 2011, International journal of urology : official journal of the Japanese Urological Association.

[14]  Y. Homma,et al.  Outline of JUA clinical guidelines for benign prostatic hyperplasia , 2011, International journal of urology : official journal of the Japanese Urological Association.

[15]  K. Takimoto,et al.  Effects of Bladder Outlet Obstruction on Properties of Ca Channels in Rat Bladder , 2022 .

[16]  L. Hill,et al.  Lack of pharmacodynamic interaction of silodosin, a highly selective alpha1a-adrenoceptor antagonist, with the phosphodiesterase-5 inhibitors sildenafil and tadalafil in healthy men. , 2010, Urology.

[17]  M. Michel,et al.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate. , 2006, British journal of pharmacology.

[18]  K. Kihara,et al.  Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities in the detrusor and proximal urethra of the rabbit. , 2002, The Journal of urology.

[19]  H. Maeda,et al.  The possible effect of nitric oxide on relaxation and noradrenaline release in the isolated rabbit urethra. , 1998, European journal of pharmacology.